{"id":4580,"date":"2025-10-01T11:30:23","date_gmt":"2025-10-01T17:30:23","guid":{"rendered":"https:\/\/www.kirtonmcconkie.com\/?p=4580"},"modified":"2025-12-18T09:13:40","modified_gmt":"2025-12-18T16:13:40","slug":"client-alert-fda-takes-aim-at-misleading-drug-ads","status":"publish","type":"post","link":"https:\/\/www.kirtonmcconkie.com\/es\/news\/client-alert-fda-takes-aim-at-misleading-drug-ads\/","title":{"rendered":"Alerta al cliente: la FDA toma medidas contra los anuncios enga\u00f1osos de medicamentos"},"content":{"rendered":"

On September 9, 2025, the White House and the U.S. Food and Drug Administration (FDA) announced extensive reforms to curb deceptive direct-to-consumer (DTC) pharmaceutical advertising<\/a>, signaling a dramatic shift toward more aggressive enforcement.<\/p>\n

 <\/p>\n

Overview<\/strong>
\nOn September 9, 2025, the White House directed the Department of Health and Human Services (HHS) and FDA to restore transparency and accountability in prescription drug advertising<\/a>. In response, FDA sent thousands of letters<\/a> demanding the removal of misleading ads and approximately 100 cease-and-desist letters to companies running deceptive campaigns. The agency also announced new rulemaking to close the \u201cadequate provision\u201d loophole, which the agency claims has enabled drug manufacturers to conceal critical safety risks in broadcast and digital ads.<\/p>\n

 <\/p>\n

FDA Is Ramping Up Deceptive DTC Drug Advertisement Enforcement<\/strong><\/p>\n

In very direct terms, FDA put the pharmaceutical industry on notice that the agency will proactively seek to combat violative deceptive DTC drug ads. FDA warned that after years of lax enforcement\u2014with FDA dramatically reducing the number of warning letters related to DTC drug advertising in recent years\u2014pharmaceutical manufacturers are now on notice that FDA intends to aggressively deploy its available enforcement tools, including AI and tech-enabled enforcement tools to proactively monitor and review DTC drug ads.<\/p>\n

 <\/p>\n

Key Takeaways<\/strong><\/p>\n